comparemela.com

Latest Breaking News On - Jim hollingshead - Page 9 : comparemela.com

Insulet (PODD) Announces FDA Clearance of Omnipod GO

Insulet (PODD) Announces FDA Clearance of Omnipod GO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAngela geryak wiczekJim hollingsheadDeborahr gordonCorporate communicationsInsulet corporationWall streetChief executiveOmnipod insulin management systemInsulin delivery system

Insulet Announces FDA Clearance of Omnipod GO, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

25.04.2023 - Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced the FDA clearance of its latest innovation, Omnipod GO, an insulin delivery device .

United statesJim hollingsheadInsulet corporationBusiness wireChief executiveOmnipod insulin management systemInsulin delivery systemInsulet stock

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDeborahr gordonAngela geryak wiczekJim hollingsheadCorporate communicationsInsulet corporationBusiness wireChief executiveOmnipod insulin management systemInsulin delivery systemInvestor relations

Basal-Only Insulin Delivery System Cleared for Patients With Type 2 Diabetes

The FDA has cleared the Omnipod GO for individuals aged ≥18 years with type 2 diabetes who typically take daily injections of long-acting insulin.

Jim hollingsheadDrug administration

Omnipod GO Receives FDA Clearance for People with Type 2 Diabetes

Announced on April 25, 2023, the FDA's clearance of the Omnipod GO marks the first-of-its-kind for a basal-only insulin pod and is indicated for use as an

Jim hollingsheadDrug administrationDrug administration us foodDrug administration logoChief executive

vimarsana © 2020. All Rights Reserved.